Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Capital Reinvestment Ratio

Latest as of September 2025: 0.64x

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A capital reinvestment ratio. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a Capital Reinvestment Ratio of 0.64x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥26.54 Million) in capital expenditures (CN¥17.01 Million). See 002864 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.64x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥26.54 Million
CNY

Capital Expenditures

CN¥17.01 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

Capital reinvestment ratio of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. This chart tracks Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's Capital Reinvestment Ratio across 13 annual periods. See 002864 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Capital Reinvestment Ratio by Year (2013–2025)

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see how efficiently does Shaanxi Panlong Pharmaceutical Group Lim generate cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.67x CN¥63.01 Million CN¥42.41 Million ▲ +28.4%
2024 0.52x CN¥156.59 Million CN¥82.05 Million ▼ -12.8%
2023 0.60x CN¥104.05 Million CN¥62.51 Million ▲ +34.9%
2022 0.45x CN¥125.36 Million CN¥55.84 Million ▼ -35.9%
2021 0.70x CN¥116.04 Million CN¥80.68 Million ▼ -9.9%
2020 0.77x CN¥92.24 Million CN¥71.18 Million ▲ +56.1%
2019 0.49x CN¥67.89 Million CN¥33.55 Million ▲ +15.4%
2018 0.43x CN¥46.85 Million CN¥20.06 Million ▼ -48.0%
2017 0.82x CN¥28.45 Million CN¥23.45 Million ▲ +199.6%
2016 0.28x CN¥61.99 Million CN¥17.06 Million ▼ -75.2%
2015 1.11x CN¥40.62 Million CN¥45.08 Million ▲ +66.2%
2014 0.67x CN¥48.56 Million CN¥32.42 Million ▼ -44.4%
2013 1.20x CN¥25.43 Million CN¥30.55 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow